| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1159 | 388 | 952 | 20 |
Hematological Oncology mostly deals with topics like Internal medicine, Oncology, Cancer research, Lymphoma and Immunology. While Internal medicine is the focus of Hematological Oncology, it also provided insights into the studies of Gastroenterology and Surgery. Regimen and Transplantation are some of the study areas of Surgery discussed.
Issues in Oncology were discussed, taking into consideration concepts from other disciplines like Relapsed refractory, Refractory, Lenalidomide, Hodgkin lymphoma and Follicular lymphoma. The work tackled in Hematological Oncology goes beyond the discipline of Cancer research as it also encompasses Diffuse large B-cell lymphoma. The Lymphoma research presented falls under the domain of Pathology.
It is mostly focused on Pathology, specifically Bone marrow. The main emphasis of Hematological Oncology is the subject of Immunology, focusing on Leukemia.
Internal medicine, Lymphoma, Immunology, Pathology and Surgery are the main subjects of interest in the journal publications. While the journal publications focused on Internal medicine, they were also able to explore topics like Gastroenterology and Oncology. The published articles address concerns in Immunology which are intertwined with other disciplines, such as Cancer research and Disease.
The journal investigates studies in Internal medicine, Oncology, Cancer research, In patient and Diffuse large B-cell lymphoma. It dives deep in exploring the relationship between the study of Internal medicine and Gastroenterology. In it, Lenalidomide, Phases of clinical research, Brentuximab vedotin, Hodgkin lymphoma and Ibrutinib are investigated in conjunction with one another to address concerns in Oncology research.
It focuses on Ibrutinib research as part of the broader topic of Chronic lymphocytic leukemia. It explores issues in Cancer research which can be linked to other research areas like B-cell lymphoma, Mantle cell lymphoma and B cell. More specifically, the research on Rituximab in the journal is related to Bendamustine.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Hematological Oncology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Hematological Oncology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 11.76% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.44% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.44% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.67% of all publications and 40.44% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Navigating a professional journey in hematological oncology can be as complex as the field itself. This area of specialty, often characterized by constant evolution and dynamic challenges, presents a myriad of opportunities for aspiring professionals. Notably, one must be well-equipped with the profound knowledge and clinical skills tied to this discipline's intricate matrices, such as Internal Medicine, Oncology, and Cancer Research. The career path requires a considerable amount of dedication and commitment, along with an ability to multitask and embrace lifelong learning given the fast-paced developments in medical research. Hematological oncologists often work closely with other medical professionals and specialists, thereby highlighting the need for apt communication skills and a collaborative mindset. Moreover, they must demonstrate a solid understanding of various related topics, which include but are not limited to, Lymphoma, Immunology, Gastroenterology, Surgery and Pathology. These professionals often find themselves in the front lines, dealing with complex cases and making critical decisions that significantly impact patients' lives. The road to becoming a successful hematological oncologist can be strenuous and complex. An aspiring candidate is required to complete a bachelor's degree, attend medical school, and specialize in hematology and oncology via residency and fellowship programs. The career also demands continuous education to stay abreast with appropriate techniques, methodologies, and the latest medical advancements related to this field. For instance, if someone wishes to further their career prospects in this field, they might want to consider an advanced specialization, such as a nurse practitioner. You can find detailed insights regarding the prerequisites, process, and opportunities related to this progression from our resource guide on how to become a nurse practitioner in Texas. Through hard work, dedication, and continuous learning, a career in Hematological Oncology can be a rewarding journey, providing an opportunity to make impactful contributions in the field of medicine, and most importantly, in the lives of patients dealing with hematological disorders.
F. Bonfiglio;A. Bruscaggin;F. Guidetti;L. Terzi di Bergamo
(2021)Tiffany Li;Hannah C. Timmins;Tracy King;Tracy King;Matthew C. Kiernan;Matthew C. Kiernan
(2020)Serena Rocchi;Paola Tacchetti;Lucia Pantani;Katia Mancuso
(2021)Davide Rossi;David M. Kurtz;Mark Roschewski;Franco Cavalli
(2020)K Ishitsuka;K Izutsu;D Maruyama;S Makita
(2021)For those interested in expanding their healthcare education beyond studying Medicine in the USA, numerous online degree options cater to various career goals. Many registered nurses seek to advance their qualifications through affordable programs, such as online RN to BSN programs. These programs offer flexibility and cost-effective routes to enhance clinical knowledge and leadership skills.
Admissions requirements can often pose challenges for prospective students. Luckily, some institutions provide nursing paths that eliminate the traditional barriers, including schools with do you have to take the TEAS test to get into nursing school policies that remove standardized entrance exams.
For those focused on healthcare management, pursuing an online Master’s in Healthcare Administration (MHA) is a worthy goal. Options like the affordable online MHA programs enable professionals to gain business and leadership expertise without sacrificing their current roles.
If a quicker entry into the healthcare workforce is desirable, exploring fast track medical LPN programs can be an excellent strategy. These programs offer accelerated training for Licensed Practical Nurses, bridging the gap between education and employment efficiently.
